Therapy
Self-Care, Destabilization, and the Holistic Nature of Psychedelics
June 21, 2024
Featuring: Kaitlin Roberson & Dr. Michele Cox, DO
In this episode of Vital Psychedelic Conversations, David interviews Kaitlin Roberson: Vital graduate and co-founder and CEO of Cacti Therapeutics, a psychedelic biotech company developing novel therapies for chronic pain; and Dr. Michele Cox, DO: current Vital student, veteran, physician, and co-founder of LifeBloom, a brand new company focusing on bringing community and connection into women’s healthcare.
In this episode of Vital Psychedelic Conversations, David interviews Kaitlin Roberson: Vital graduate and co-founder and CEO of Cacti Therapeutics, a psychedelic biotech company developing novel therapies for chronic pain; and Dr. Michele Cox, DO: current Vital student, veteran, physician, and co-founder of LifeBloom, a brand new company focusing on bringing community and connection into women’s healthcare.
They talk about their work: Roberson’s research on trauma and chronic pain, and why she feels that working in the pharma industry is a calling; and Cox’s framework as an osteopath, the value she’s found in touch and connection, and how she explains to clients what to expect when undergoing ketamine treatment.
They discuss:
- Why psychedelics are such useful interventions
- The body’s ability to tell us what’s wrong, as long we’re listening
- The destabilization that can occur after a big experience: If you don’t have a good support system, is it really the right time?
- Self-care and our tendency to never feel like we’re good enough
- How there is energy in everything and we should all recognize that more
And, as Vital students, they talk about what they hoped to get out of Vital and how it delivered more than expected. If you’re just discovering Vital, be sure to check out the website and fill out an application. Secure your spot and take advantage of the Early Bird discount!
Links
National Institute for the Clinical Application of Behavioral Medicine’s infograph
